Biblio
Erratum: βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum. Theranostics. 2023;13(13):4391.
. βKlotho is identified as a target for theranostics in non-small cell lung cancer. Theranostics. 2019;9(25):7474-7489.
. The Prodomain-Containing BMP9 Produced from a Stable Line Effectively Regulates the Differentiation of Mesenchymal Stem Cells. Int J Med Sci. 2016;13(1):8-18.